Benoit SL - Search Results

1

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party.

Eron JJ, Benoit SL, Jemsek J, MacArthur RD, Santana J, Quinn JB, Kuritzkes DR, Fallon MA, Rubin M. Eron JJ, et al. Among authors: benoit sl. N Engl J Med. 1995 Dec 21;333(25):1662-9. doi: 10.1056/NEJM199512213332502. N Engl J Med. 1995. PMID: 7477218 Free article. Clinical Trial.

2

Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.

Bartlett JA, Benoit SL, Johnson VA, Quinn JB, Sepulveda GE, Ehmann WC, Tsoukas C, Fallon MA, Self PL, Rubin M. Bartlett JA, et al. Among authors: benoit sl. Ann Intern Med. 1996 Aug 1;125(3):161-72. doi: 10.7326/0003-4819-125-3-199608010-00001. Ann Intern Med. 1996. PMID: 8686973 Clinical Trial.

3

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, Rubin M, Simberkoff MS, Hamilton JD. O'Brien WA, et al. N Engl J Med. 1996 Feb 15;334(7):426-31. doi: 10.1056/NEJM199602153340703. N Engl J Med. 1996. PMID: 8552144 Free article.

4

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

Kuritzkes DR, Quinn JB, Benoit SL, Shugarts DL, Griffin A, Bakhtiari M, Poticha D, Eron JJ, Fallon MA, Rubin M. Kuritzkes DR, et al. Among authors: benoit sl. AIDS. 1996 Aug;10(9):975-81. doi: 10.1097/00002030-199610090-00007. AIDS. 1996. PMID: 8853730 Clinical Trial.

5

Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group.

Merigan TC, Amato DA, Balsley J, Power M, Price WA, Benoit S, Perez-Michael A, Brownstein A, Kramer AS, Brettler D, et al. Merigan TC, et al. Blood. 1991 Aug 15;78(4):900-6. Blood. 1991. PMID: 1831059 Free article. Clinical Trial.

6

Nickel chelation therapy as an approach to combat multi-drug resistant enteric pathogens.

Benoit SL, Schmalstig AA, Glushka J, Maier SE, Edison AS, Maier RJ. Benoit SL, et al. Sci Rep. 2019 Sep 25;9(1):13851. doi: 10.1038/s41598-019-50027-0. Sci Rep. 2019. PMID: 31554822 Free PMC article.

7

Site-directed mutagenesis of Campylobacter concisus respiratory genes provides insight into the pathogen's growth requirements.

Benoit SL, Maier RJ. Benoit SL, et al. Sci Rep. 2018 Sep 21;8(1):14203. doi: 10.1038/s41598-018-32509-9. Sci Rep. 2018. PMID: 30242194 Free PMC article.

8

Author Correction: Nickel chelation therapy as an approach to combat multi-drug resistant enteric pathogens.

Benoit SL, Schmalstig AA, Glushka J, Maier SE, Edison AS, Maier RJ. Benoit SL, et al. Sci Rep. 2019 Nov 25;9(1):17813. doi: 10.1038/s41598-019-54299-4. Sci Rep. 2019. PMID: 31767909 Free PMC article.

9

The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation.

Benoit SL, Maier RJ. Benoit SL, et al. Sci Rep. 2021 Mar 23;11(1):6622. doi: 10.1038/s41598-021-86060-1. Sci Rep. 2021. PMID: 33758258 Free PMC article.

10

A two-hybrid system reveals previously uncharacterized protein-protein interactions within the Helicobacter pylori NIF iron-sulfur maturation system.

Benoit SL, Agudelo S, Maier RJ. Benoit SL, et al. Sci Rep. 2021 May 24;11(1):10794. doi: 10.1038/s41598-021-90003-1. Sci Rep. 2021. PMID: 34031459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters